CATL’s 6.7 per cent discount to its Shenzhen-traded shares is much lower than the average 25 per cent discount for ...

Shares of the restaurant chain began trading at HK$7.19 per share, unchanged from the offer price, before plunging 7 per cent ...

Chinese biotech company Bliss Biopharmaceutical (BlissBio) is reportedly considering a Hong Kong initial public offering (IPO ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Auntea Jenny is the latest of a string of tea companies to list in Hong Kong, just this year. Emily Tan takes a closer look at that market action.

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

The underwriters on Hengrui Pharmaceutical Hong Kong listing are represented by Herbert Smith Freehills and Jingtian & ...

The China-based casual dining brand began trading its IPO after pricing its 168,364,000 shares at HKD 7.19 per share.

Chinese EV battery leader CATL plans a $4 billion IPO in Hong Kong set for May 20, 2023. The company, a major supplier for ...